ArticleCureus2026
Case of Hemolysis, Elevated Liver Enzymes, and Low Platelet Count (HELLP) Syndrome Complicated by Sepsis: Challenges in Diagnosis and Management.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hemolysis, Elevated Liver Enzymes, and Low Platelet Count (HELLP) syndrome, complicated by sepsis, is a rare yet highly lethal obstetric emergency characterized by synergistic endothelial dysfunction and coagulopathy. This condition presents significant diagnostic difficulties because of its similarities with severe preeclampsia and unusual sepsis. We present the case of a 30-year-old primigravida at 28 weeks' gestation. She was hospitalized for oligohydramnios and mild hypertension, but quickly progressed to experiencing severe epigastric pain, fever, and multiorgan failure. Laboratory tests revealed thrombocytopenia (51 × 10⁹/L), microangiopathic hemolysis with schistocytes, hepatitis (aspartate aminotransferase 995 U/L), and hyperinflammation (interleukin-6 >500 pg/mL, procalcitonin 35.3 ng/mL). HELLP syndrome was confirmed after the exclusion of other thrombotic microangiopathies. Sepsis preceded the development of HELLP syndrome, with Klebsiella pneumoniae bacteremia and influenza A infection identified as the primary etiologies of sepsis. The multidisciplinary management involved emergent cesarean delivery, broad-spectrum antibiotics, plasma transfusion, and immunomodulation, resulting in progressive maternal recovery and neonatal survival despite premature birth. This case highlights the crucial importance of prompt sepsis screening in HELLP patients experiencing swift clinical decline. It also emphasizes the significance of protocolized interventions guided by Sequential Organ Failure Assessment and coordinated multidisciplinary efforts to reduce the combined risks of maternal-fetal mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.